The BioWorld Biotechnology State of the Industry Report 2001, the most comprehensive review and analysis of the business, science and government regulation of the biotechnology industry, is now available.
The record-breaking year in financings, along with the multitude of business deals and scientific progress in 2000, required 437 pages to detail, 113 more pages than needed to recap the previous year. The report tracks the year in which biotechnology companies added $36.2 billion to their balance sheets through public and private financings, and looks ahead to some of the trends likely to shape the sector this year.
The report chronicles the financings, the sequencing of the human genome, the regulatory issues and Wall Street performances that shaped the year.
To purchase a copy of the BioWorld Biotechnology State of the Industry Report 2001, call (800) 688-2421 or (404) 262-5476.